Claire Higham

4.1k total citations
54 papers, 1.9k citations indexed

About

Claire Higham is a scholar working on Endocrinology, Diabetes and Metabolism, Surgery and Oncology. According to data from OpenAlex, Claire Higham has authored 54 papers receiving a total of 1.9k indexed citations (citations by other indexed papers that have themselves been cited), including 30 papers in Endocrinology, Diabetes and Metabolism, 19 papers in Surgery and 10 papers in Oncology. Recurrent topics in Claire Higham's work include Pituitary Gland Disorders and Treatments (21 papers), Growth Hormone and Insulin-like Growth Factors (20 papers) and Adrenal and Paraganglionic Tumors (9 papers). Claire Higham is often cited by papers focused on Pituitary Gland Disorders and Treatments (21 papers), Growth Hormone and Insulin-like Growth Factors (20 papers) and Adrenal and Paraganglionic Tumors (9 papers). Claire Higham collaborates with scholars based in United Kingdom, Germany and United States. Claire Higham's co-authors include Peter Trainer, Anne Clark, Michael L. Gross, Gudmundur Johannsson, Stephen M. Shalet, Paul E. Fraser, Georg Brabant, Paul Lorigan, Louise C. Serpell and Jesús Zurdo and has published in prestigious journals such as The Lancet, Journal of Molecular Biology and Endocrine Reviews.

In The Last Decade

Claire Higham

53 papers receiving 1.9k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Claire Higham United Kingdom 24 773 460 412 411 384 54 1.9k
Jun Ishii Japan 28 718 0.9× 700 1.5× 373 0.9× 473 1.2× 376 1.0× 152 2.4k
Kazuhiko Sakaguchi Japan 23 552 0.7× 642 1.4× 207 0.5× 377 0.9× 203 0.5× 94 1.7k
Pamela Clark United States 17 241 0.3× 361 0.8× 369 0.9× 327 0.8× 297 0.8× 29 1.7k
Helena E. Miettinen Finland 23 548 0.7× 846 1.8× 417 1.0× 1.1k 2.6× 247 0.6× 36 2.4k
Robert N. Fontaine United States 26 353 0.5× 637 1.4× 208 0.5× 509 1.2× 177 0.5× 48 2.4k
Brian J. Lee United States 21 377 0.5× 845 1.8× 420 1.0× 256 0.6× 120 0.3× 44 2.2k
S. Friis Denmark 25 235 0.3× 430 0.9× 586 1.4× 518 1.3× 123 0.3× 52 2.4k
J D Teale United Kingdom 26 735 1.0× 492 1.1× 279 0.7× 181 0.4× 116 0.3× 51 1.6k
Michele Marinò Italy 35 2.1k 2.7× 495 1.1× 138 0.3× 149 0.4× 368 1.0× 144 3.6k
Pascale de Lonlay France 26 1.0k 1.3× 685 1.5× 132 0.3× 653 1.6× 199 0.5× 71 2.0k

Countries citing papers authored by Claire Higham

Since Specialization
Citations

This map shows the geographic impact of Claire Higham's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Claire Higham with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Claire Higham more than expected).

Fields of papers citing papers by Claire Higham

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Claire Higham. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Claire Higham. The network helps show where Claire Higham may publish in the future.

Co-authorship network of co-authors of Claire Higham

This figure shows the co-authorship network connecting the top 25 collaborators of Claire Higham. A scholar is included among the top collaborators of Claire Higham based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Claire Higham. Claire Higham is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Korbonits, Márta, Joanne Blair, John Ayuk, et al.. (2024). Consensus guideline for the diagnosis and management of pituitary adenomas in childhood and adolescence: Part 2, specific diseases. Nature Reviews Endocrinology. 20(5). 290–309. 8 indexed citations
2.
Cooksley, Tim, Avinash Gupta, Jan Hoong Ho, et al.. (2023). Immune checkpoint inhibitor-mediated hypophysitis: no place like home. Clinical Medicine. 23(1). 81–84. 5 indexed citations
3.
Taylor, Sally, et al.. (2023). Understanding the impact of radiotherapy related insufficiency fractures and exploring satisfaction with two existing patient reported outcome measures: A qualitative interview study. Technical Innovations & Patient Support in Radiation Oncology. 27. 100210–100210. 1 indexed citations
4.
Chatzimavridou-Grigoriadou, Victoria, et al.. (2023). Radiotherapy-related insufficiency fractures and bone mineral density: what is the connection?. Endocrine Connections. 12(7). 1 indexed citations
5.
Chatzimavridou-Grigoriadou, Victoria, Lisa Barraclough, Robert G. Bristow, et al.. (2022). RadBone: bone toxicity following pelvic radiotherapy – a prospective randomised controlled feasibility study evaluating a musculoskeletal health package in women with gynaecological cancers undergoing pelvic radiotherapy. BMJ Open. 12(6). e056600–e056600. 4 indexed citations
6.
Boguszewski, Margaret Cristina da Silva, César Luiz Boguszewski, Wassim Chemaitilly, et al.. (2021). Safety of growth hormone (GH) treatment in GH deficient children and adults treated for cancer and non-malignant intracranial tumors—a review of research and clinical practice. Pituitary. 24(5). 810–827. 23 indexed citations
7.
Cooksley, Tim, et al.. (2020). Emergency ambulatory outpatient management of immune-mediated hypophysitis. Supportive Care in Cancer. 28(9). 3995–3999. 8 indexed citations
8.
Berman, Richard, Andrew Davies, Tim Cooksley, et al.. (2020). Supportive Care: An Indispensable Component of Modern Oncology. Clinical Oncology. 32(11). 781–788. 75 indexed citations
9.
10.
Pearce, Simon H. S., Colin Dayan, David C. Wraith, et al.. (2019). Antigen-Specific Immunotherapy with Thyrotropin Receptor Peptides in Graves' Hyperthyroidism: A Phase I Study. Thyroid. 29(7). 1003–1011. 77 indexed citations
11.
Owen, Laura, Phillip J. Monaghan, Anne Armstrong, et al.. (2019). Oestradiol measurement during fulvestrant treatment for breast cancer. British Journal of Cancer. 120(4). 404–406. 16 indexed citations
12.
Higham, Claire & Sara Faithfull. (2015). Bone Health and Pelvic Radiotherapy. Clinical Oncology. 27(11). 668–678. 49 indexed citations
13.
Higham, Claire, A. B. Atkinson, Simon Aylwin, et al.. (2012). Effective Combination Treatment with Cabergoline and Low-Dose Pegvisomant in Active Acromegaly: A Prospective Clinical Trial. The Journal of Clinical Endocrinology & Metabolism. 97(4). 1187–1193. 76 indexed citations
14.
Völzke, Henry, Matthias Nauck, Rainer Rettig, et al.. (2009). Association between hepatic steatosis and serum IGF1 and IGFBP-3 levels in a population-based sample. European Journal of Endocrinology. 161(5). 705–713. 76 indexed citations
15.
Higham, Claire, et al.. (2009). Successful use of weekly pegvisomant administration in patients with acromegaly. European Journal of Endocrinology. 161(1). 21–25. 30 indexed citations
16.
Higham, Claire, Julia Thomas, Will Drake, & Peter Trainer. (2008). Successful use of once weekly pegvisomant administration in patients with acromegaly. 15. 1 indexed citations
17.
Higham, Claire, et al.. (2008). Long‐term experience of pegvisomant therapy as a treatment for acromegaly. Clinical Endocrinology. 71(1). 86–91. 50 indexed citations
18.
Higham, Claire, Louise C. Serpell, Jesús Zurdo, et al.. (2001). Identification of a novel human islet amyloid polypeptide β-sheet domain and factors influencing fibrillogenesis. Journal of Molecular Biology. 308(3). 515–525. 207 indexed citations
19.
Gribble, Fiona M., Timothy M. E. Davis, Claire Higham, Anne Clark, & Frances M. Ashcroft. (2000). The antimalarial agent mefloquine inhibits ATP‐sensitive K‐channels. British Journal of Pharmacology. 131(4). 756–760. 74 indexed citations
20.
Gribble, Fiona M., et al.. (1997). The anti-malarial drugs Mefloquine and Halofantrine inhibit ATP-sensitive potassium channels. Diabetologia. 40. 401–401. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Jun Ishii Breakdown of academic impact, for papers by Kazuhiko Sakaguchi Breakdown of academic impact, for papers by Pamela Clark Breakdown of academic impact, for papers by Helena E. Miettinen Breakdown of academic impact, for papers by Robert N. Fontaine Breakdown of academic impact, for papers by Brian J. Lee Breakdown of academic impact, for papers by S. Friis Breakdown of academic impact, for papers by J D Teale Breakdown of academic impact, for papers by Michele Marinò Breakdown of academic impact, for papers by Pascale de Lonlay
Rankless by CCL
2026